<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>18(8)</volume><submitter>Triggianese P</submitter><funding>Università degli Studi di Siena</funding><pubmed_abstract>To characterize clinical and laboratory signs of patients with Still's disease experiencing macrophage activation syndrome (MAS) and identify factors associated with MAS development. Patients with Still's disease classified according to internationally accepted criteria were enrolled in the AutoInflammatory Disease Alliance (AIDA) Still's Disease Registry. Clinical and laboratory features observed during the inflammatory attack complicated by MAS were included in univariate and multivariate logistic regression analysis to identify factors associated to MAS development. A total of 414 patients with Still's disease were included; 39 (9.4%) of them developed MAS during clinical history. At univariate analyses, the following variables were significantly associated with MAS: classification of a</pubmed_abstract><journal>Internal and emergency medicine</journal><pagination>2231-2243</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10635948</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry.</pubmed_title><pmcid>PMC10635948</pmcid><pubmed_authors>Ruscitti P</pubmed_authors><pubmed_authors>Kourtesi K</pubmed_authors><pubmed_authors>Dagna L</pubmed_authors><pubmed_authors>Frassi M</pubmed_authors><pubmed_authors>Frediani B</pubmed_authors><pubmed_authors>Tufan A</pubmed_authors><pubmed_authors>Gidaro A</pubmed_authors><pubmed_authors>Carubbi F</pubmed_authors><pubmed_authors>Tharwat S</pubmed_authors><pubmed_authors>La Torre F</pubmed_authors><pubmed_authors>Al-Maghlouth I</pubmed_authors><pubmed_authors>Govoni M</pubmed_authors><pubmed_authors>Giacomelli R</pubmed_authors><pubmed_authors>Ragab G</pubmed_authors><pubmed_authors>Chimenti MS</pubmed_authors><pubmed_authors>Kardas RC</pubmed_authors><pubmed_authors>Sevik G</pubmed_authors><pubmed_authors>Sota J</pubmed_authors><pubmed_authors>Gaggiano C</pubmed_authors><pubmed_authors>Ogunjimi B</pubmed_authors><pubmed_authors>Sfikakis PP</pubmed_authors><pubmed_authors>Simonini G</pubmed_authors><pubmed_authors>Iagnocco A</pubmed_authors><pubmed_authors>Saad MA</pubmed_authors><pubmed_authors>Spedicato V</pubmed_authors><pubmed_authors>Sfriso P</pubmed_authors><pubmed_authors>Conforti A</pubmed_authors><pubmed_authors>Caggiano V</pubmed_authors><pubmed_authors>Di Cola I</pubmed_authors><pubmed_authors>Monti S</pubmed_authors><pubmed_authors>Del Giudice E</pubmed_authors><pubmed_authors>Fabiani C</pubmed_authors><pubmed_authors>Cipriani P</pubmed_authors><pubmed_authors>Lo Gullo A</pubmed_authors><pubmed_authors>Balistreri A</pubmed_authors><pubmed_authors>Bindoli S</pubmed_authors><pubmed_authors>Tombetti E</pubmed_authors><pubmed_authors>Laskari K</pubmed_authors><pubmed_authors>Navarini L</pubmed_authors><pubmed_authors>Wiesik-Szewczyk E</pubmed_authors><pubmed_authors>Erten S</pubmed_authors><pubmed_authors>Hinojosa-Azaola A</pubmed_authors><pubmed_authors>Cartocci A</pubmed_authors><pubmed_authors>Asfina KN</pubmed_authors><pubmed_authors>Conti G</pubmed_authors><pubmed_authors>Sebastiani GD</pubmed_authors><pubmed_authors>Iannone F</pubmed_authors><pubmed_authors>Rubegni G</pubmed_authors><pubmed_authors>Vitale A</pubmed_authors><pubmed_authors>Ciccia F</pubmed_authors><pubmed_authors>Campochiaro C</pubmed_authors><pubmed_authors>Olivieri AN</pubmed_authors><pubmed_authors>Karamanakos A</pubmed_authors><pubmed_authors>Dagostin MA</pubmed_authors><pubmed_authors>de Brito Antonelli IP</pubmed_authors><pubmed_authors>Alibaz-Oner F</pubmed_authors><pubmed_authors>Gentileschi S</pubmed_authors><pubmed_authors>Cantarini L</pubmed_authors><pubmed_authors>Nuzzolese R</pubmed_authors><pubmed_authors>Bartoloni E</pubmed_authors><pubmed_authors>Ali HH</pubmed_authors><pubmed_authors>Triggianese P</pubmed_authors><pubmed_authors>Direskeneli H</pubmed_authors><pubmed_authors>Fotis L</pubmed_authors><pubmed_authors>Hernandez-Rodriguez J</pubmed_authors><pubmed_authors>Martin-Nares E</pubmed_authors><pubmed_authors>Marino A</pubmed_authors><pubmed_authors>Lopalco G</pubmed_authors><pubmed_authors>Iacono D</pubmed_authors><pubmed_authors>Makowska J</pubmed_authors><pubmed_authors>De Paulis A</pubmed_authors><pubmed_authors>Maggio MC</pubmed_authors><pubmed_authors>Emmi G</pubmed_authors><pubmed_authors>Patrone M</pubmed_authors><pubmed_authors>Mayrink Giardini HA</pubmed_authors><pubmed_authors>Viapiana O</pubmed_authors><pubmed_authors>Torres-Ruiz J</pubmed_authors><pubmed_authors>Maier A</pubmed_authors><pubmed_authors>Tarsia M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry.</name><description>To characterize clinical and laboratory signs of patients with Still's disease experiencing macrophage activation syndrome (MAS) and identify factors associated with MAS development. Patients with Still's disease classified according to internationally accepted criteria were enrolled in the AutoInflammatory Disease Alliance (AIDA) Still's Disease Registry. Clinical and laboratory features observed during the inflammatory attack complicated by MAS were included in univariate and multivariate logistic regression analysis to identify factors associated to MAS development. A total of 414 patients with Still's disease were included; 39 (9.4%) of them developed MAS during clinical history. At univariate analyses, the following variables were significantly associated with MAS: classification of a</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Nov</publication><modification>2026-06-03T15:05:39.465Z</modification><creation>2025-04-20T10:07:31.434Z</creation></dates><accession>S-EPMC10635948</accession><cross_references><pubmed>37828268</pubmed><doi>10.1007/s11739-023-03408-3</doi></cross_references></HashMap>